Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with RXRX: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
RXRX
Recursion Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
RXRX
Recursion Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
460.76
▼
−1.01%
Mkt cap
$251.6B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
RXRX
Recursion Pharmaceuticals, Inc.
Change
3.67
▼
−4.18%
Regular session
Nov 3 '26
Mkt cap
$2.4B
Revenue
$19M
Q3 FY26
Revenue
$75M
FY25
vs
Compare
Regular session
Nov 3 '26
AMGN
Amgen Inc
vs
RXRX
Recursion Pharmaceuticals, Inc.
460.76
▼
−1.01%
Price
3.67
▼
−4.18%
$251.6B
Mkt cap
$2.4B
Q2 FY26
$10.1B
Revenue
$19M
Q3 FY26
FY25
$36.8B
Revenue
$75M
FY25
Change
Change
AMGN
460.76
▼
−1.01%
vs
RXRX
3.67
▼
−4.18%
Regular session
Nov 3 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only RXRX
14
NVDA
Nvidia
supplier
GOOGL
Google Cloud
supplier
TEM
Tempus AI
supplier
SNY
Sanofi
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
10 more · RXRX chain
›